Dear Client,
As part of our ongoing commitment to ensuring the security of your online trading experience, we would like to inform you of our protocol for addressing any suspicious activities observed on your trading account
Should you notice any irregularities or suspect unauthorized access to your account, we kindly request that you take immediate action by following the steps outlined below:
Send an Email Please send an email to stoptrade@acml.in from your registered email ID. In the email, briefly outline the suspicious activity you have observed.
Phone Call Alternatively, you can call us at 07968101000 Ext: 1 from your registered mobile number. This will enable us to address your concerns promptly.
When contacting us, please ensure you provide the following details:
By providing this information, you enable us to swiftly investigate and take appropriate measures to safeguard your account.
Your security and peace of mind are of utmost importance to us, and we appreciate your cooperation in maintaining the integrity of your trading account.
In the past one year, the stock has fallen 2.32% while the benchmark Sensex has risen 8.65% during the same period.
On the technical front, the stock's RSI (relative strength index) stood at 28.39. The RSI oscillates between zero and 100. Traditionally, the RSI is considered overbought when above 70 and oversold when below 30.
The stock was trading below its 50-day, 100-day and 200-day simple moving average (SMA) placed at 838.12, 898.80 and 841.21, respectively.
Anupam Rasayan India is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India.
On a consolidated basis, Anupam Rasayan India reported 108.2% surge in net profit to Rs 46.10 crore in Q4 FY22 from Rs 22.14 crore registered in Q4 FY21. Net sales grew 16.8% to Rs 317.24 crore in Q4 FY22 over Rs 271.67 crore in Q4 FY21.
The company's board will meet on 24 May 2022 to consider raising funds through issue of equity shares, and or bonds. This may include foreign currency convertible bonds/debentures/non-convertible debt instruments along with warrants/convertible debentures/securities and/or any other equity based instruments/securities by way of qualified institutions placement or rights issue or preferential allotment, or through any other permissible mode or any combination thereof of any of the above.
Powered by Capital Market - Live News